{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:03:02Z","timestamp":1766023382294,"version":"3.48.0"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/fcfo5076","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:47:42Z","timestamp":1730771262000},"page":"6072-6096","source":"Crossref","is-referenced-by-count":1,"title":["Dystrobrevin beta is a promising prognostic biomarker and therapeutic target for hepatocellular carcinoma"],"prefix":"10.62347","volume":"16","author":[{"given":"Jin","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM and Pawlik TM. Management of hepatocellular carcinoma: a review. JAMA Surg 2023; 158: 410-420.","journal-title":"JAMA Surg"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"AG","year":"2023","unstructured":"Singal AG, Kanwal F and Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 2023; 20: 864-884.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.21037\/tcr-22-563","article-title":"Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis","volume":"11","author":"Wang","year":"2022","unstructured":"Wang K, Wang R, Liu S, Peng G, Yu H and Wang X. Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis. Transl Cancer Res 2022; 11: 580-590.","journal-title":"Transl Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","unstructured":"Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE and Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 2023; 29: 1243-1260.","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"781820","DOI":"10.3389\/fonc.2022.781820","article-title":"Clinical applications of liquid biopsy in hepatocellular carcinoma","volume":"12","author":"Yang","year":"2022","unstructured":"Yang JC, Hu JJ, Li YX, Luo W, Liu JZ and Ye DW. Clinical applications of liquid biopsy in hepatocellular carcinoma. Front Oncol 2022; 12: 781820.","journal-title":"Front Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/cancers15072070","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"15","author":"Hagiwara","year":"2023","unstructured":"Hagiwara S, Nishida N and Kudo M. Advances in immunotherapy for hepatocellular carcinoma. Cancers (Basel) 2023; 15: 2070.","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","unstructured":"Wang Y and Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 2023; 42: 629-652.","journal-title":"Cancer Metastasis Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1073\/pnas.95.1.241","article-title":"beta-dystrobrevin, a member of the dystrophin-related protein family","volume":"95","author":"Blake","year":"1998","unstructured":"Blake DJ, Nawrotzki R, Loh NY, Gorecki DC and Davies KE. beta-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci U S A 1998; 95: 241-246.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jmb.2007.06.019","article-title":"Association of dystrobrevin and regulatory subunit of protein kinase A: a new role for dystrobrevin as a scaffold for signaling proteins","volume":"371","author":"Ceccarini","year":"2007","unstructured":"Ceccarini M, Grasso M, Veroni C, Gambara G, Artegiani B, Macchia G, Ramoni C, Torreri P, Mallozzi C, Petrucci TC and Macioce P. Association of dystrobrevin and regulatory subunit of protein kinase A: a new role for dystrobrevin as a scaffold for signaling proteins. J Mol Biol 2007; 371: 1174-1187.","journal-title":"J Mol Biol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Quaranta MT, Spinello I, Paolillo R, Macchia G, Boe A, Ceccarini M, Labbaye C and Macioce P. Identification of beta-dystrobrevin as a direct target of miR-143: involvement in early stages of neural differentiation. PLoS One 2016; 11: e0156325.","DOI":"10.1371\/journal.pone.0156325"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"24740","DOI":"10.1074\/jbc.M109.090654","article-title":"The interaction with HMG20a\/b proteins suggests a potential role for beta-dystrobrevin in neuronal differentiation","volume":"285","author":"Artegiani","year":"2010","unstructured":"Artegiani B, Labbaye C, Sferra A, Quaranta MT, Torreri P, Macchia G, Ceccarini M, Petrucci TC and Macioce P. The interaction with HMG20a\/b proteins suggests a potential role for beta-dystrobrevin in neuronal differentiation. J Biol Chem 2010; 285: 24740-24750.","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1007\/s11033-012-1892-5","article-title":"Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells","volume":"39","author":"VV","year":"2012","unstructured":"Borutinskaite VV, Magnusson KE and Navakauskiene R. Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells. Mol Biol Rep 2012; 39: 10179-10186.","journal-title":"Mol Biol Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cca.2018.10.002","article-title":"Long non-coding RNA HOXD-AS1 in cancer","volume":"487","author":"Li","year":"2018","unstructured":"Li L, Wang Y, Zhang X, Huang Q, Diao Y, Yin H and Liu H. Long non-coding RNA HOXD-AS1 in cancer. Clin Chim Acta 2018; 487: 197-201.","journal-title":"Clin Chim Acta"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jcb.29206","article-title":"Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK\/ERK pathway","volume":"121","author":"Sun","year":"2020","unstructured":"Sun J, Guo Y, Bie B, Zhu M, Tian H, Tian J, Li J, Yang Y, Ji F, Kong G and Li Z. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK\/ERK pathway. J Cell Biochem 2020; 121: 443-457.","journal-title":"J Cell Biochem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R and Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 2013; 14: 7.","journal-title":"BMC Bioinformatics"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW and Liu XS. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 2018; 24: 1550-1558.","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, Ramaswamy S, Futreal PA, Haber DA, Stratton MR, Benes C, McDermott U and Garnett MJ. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013; 41: D955-D961.","DOI":"10.1093\/nar\/gks1111"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y and Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 2023; 24: bbac558.","DOI":"10.1093\/bib\/bbac558"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-017-0680-1","article-title":"STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4","volume":"16","author":"Wang","year":"2017","unstructured":"Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, Deng X, Jin H, Wang N, Wang C, Zhao F, Fang J, Yao M, Fan J and Qin W. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer 2017; 16: 136.","journal-title":"Mol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12935-020-01217-8","article-title":"LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326\/SLC27A4","volume":"20","author":"Ji","year":"2020","unstructured":"Ji W, Wang Q and Yang J. LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326\/SLC27A4. Cancer Cell Int 2020; 20: 161.","journal-title":"Cancer Cell Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 6.","journal-title":"Nat Rev Dis Primers"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v13.i1.1","article-title":"Molecular and genetic markers in hepatocellular carcinoma: in silico analysis to clinical validation (current limitations and future promises)","volume":"13","author":"El-Nakeep","year":"2022","unstructured":"El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: in silico analysis to clinical validation (current limitations and future promises). World J Gastrointest Pathophysiol 2022; 13: 1-14.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1002\/jnr.21186","article-title":"beta-dystrobrevin, a kinesin-binding receptor, interacts with the extracellular matrix components pancortins","volume":"85","author":"Veroni","year":"2007","unstructured":"Veroni C, Grasso M, Macchia G, Ramoni C, Ceccarini M, Petrucci TC and Macioce P. beta-dystrobrevin, a kinesin-binding receptor, interacts with the extracellular matrix components pancortins. J Neurosci Res 2007; 85: 2631-2639.","journal-title":"J Neurosci Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-017-0676-x","article-title":"The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma","volume":"16","author":"Lu","year":"2017","unstructured":"Lu S, Zhou J, Sun Y, Li N, Miao M, Jiao B and Chen H. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma. Mol Cancer 2017; 16: 125.","journal-title":"Mol Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A and Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444.","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1038\/s41598-019-40078-8","article-title":"Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization","volume":"9","author":"Lee","year":"2019","unstructured":"Lee HL, Jang JW, Lee SW, Yoo SH, Kwon JH, Nam SW, Bae SH, Choi JY, Han NI and Yoon SK. Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci Rep 2019; 9: 3260.","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1523\/JNEUROSCI.12-05-01802.1992","article-title":"Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons","volume":"12","author":"SJ","year":"1992","unstructured":"Pleasure SJ, Page C and Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 1992; 12: 1802-1815.","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/cas.15238","article-title":"hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2\/M1 macrophages through the miR-139-3p\/CCL5 axis","volume":"113","author":"Cao","year":"2022","unstructured":"Cao P, Ma B, Sun D, Zhang W, Qiu J, Qin L and Xue X. hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2\/M1 macrophages through the miR-139-3p\/CCL5 axis. Cancer Sci 2022; 113: 634-647.","journal-title":"Cancer Sci"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/10\/ajtr0157600.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:05Z","timestamp":1766023085000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/10\/ajtr0157600.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/fcfo5076","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2024]]}}}